Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
CAMBRIDGE, MA—Rahmer Peter, the Chief Company Growth Officer at Relay Therapeutics, Inc. (NASDAQ:RLAY), just lately executed a inventory sale transaction. The corporate, at present valued at $688 million, has seen its shares decline 62% over the previous yr and is…
CAMBRIDGE, MA—Donald A. Bergstrom, the President of Analysis and Growth at Relay Therapeutics, Inc. (NASDAQ:RLAY), has bought 657 shares of the corporate’s frequent inventory. The transaction, which occurred on December 27, 2024, was executed at a worth of $4.38 per…
CAMBRIDGE, MA—Thomas Catinazzo, the Chief Monetary Officer of Relay Therapeutics, Inc. (NASDAQ:RLAY), lately offered a good portion of his holdings within the firm. In line with a current SEC submitting, Catinazzo offered a complete of 4,865 shares of widespread inventory…
On December 27, Lynx1 Capital Administration LP, a big shareholder in Passage BIO, Inc. (NASDAQ:PASG), acquired 373,645 shares of the corporate’s frequent inventory. The shares had been bought at a weighted common value of $0.6451, with the transaction totaling roughly…
Genesis Park II LP, a big shareholder in Redwire Corp (NYSE:RDW), has offered a portion of its holdings within the firm, in keeping with a current SEC submitting. The transactions, which befell on December 27 and December 30, concerned the…
Joshua C. Lee, the Basic Counsel of Origin Supplies, Inc. (NASDAQ:ORGN), not too long ago reported a sale of 25,000 shares of the corporate’s widespread inventory. The shares had been offered on December 27, 2024, at a weighted-average value of…
Matthew T. Plavan, the CFO and COO of Origin Supplies, Inc. (NASDAQ:ORGN), just lately bought 24,500 shares of the corporate’s frequent inventory. The transaction, dated December 27, 2024, was executed at a weighted-average worth of $1.0249 per share, totaling roughly…
In a current transaction, Eyal C. Attar, Chief Medical (TASE:PMCN) Officer of Vor Biopharma Inc. (NASDAQ:VOR), offered 10,334 shares of the corporate’s frequent inventory. The shares had been offered at a value of $1.25 every, amounting to a complete of…
WEST SACRAMENTO, CA—John Bissell, CEO and Director of Origin Supplies, Inc. (NASDAQ:ORGN), not too long ago offered 55,000 shares of the corporate’s frequent inventory, valued at roughly $55,000. The transaction occurred on December 27, 2024, with shares offered at a…
Genworth Holdings, Inc. (NYSE:GNW) just lately bought 367,955 shares of Enact Holdings, Inc. (NASDAQ:ACT) widespread inventory, in accordance with a submitting with the Securities and Trade Fee. The shares had been bought at a mean value of $33.95 every, leading…
